Delayed tacrolimus leukoencephalopathy, a rare and reversible cause of dementia

Neurology: Neuroimmunology and NeuroInflammation

Volumn 4, Issue 2, 2017, Pages

  Barragán Martínez, Diego ^a   Simarro Díaz, Ana ^a   Calleja Castaño, Patricia ^a   Hernández Laín, Aurelio ^a,b,c   Ramos González, Ana ^a,b,c   Villarejo Galende, Alberto ^a,b,c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Universidad Complutense   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; TACROLIMUS;

AGED; ARTICLE; BRAIN BIOPSY; BRAIN RADIOGRAPHY; CASE REPORT; CAUSAL ATTRIBUTION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DEMENTIA; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; LEUKOENCEPHALOPATHY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY SCLEROSING CHOLANGITIS; RARE DISEASE;

EID: 85021041031     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000319     Document Type: Article

References (5)

1. Bechstein WO. Neurotoxicity of calcineurin inhibitors: Impact and clinical management. Transpl Int 2000;13: 313-326.
2. Kim SH, KimW, Lee KW, Hong EK, Kim HJ. Tumefactive demyelination, an uncommon form of tacrolimus neurotoxicity. Neurology 2011;76:672-674.
3. Vizzini G, Asaro M, Miraglia R, et al. Changing picture of central nervous system complications in liver transplant recipients. Liver Transpl 2011;17:1279-1285.
4. Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000;69:467-472.
5. Thyagarajan GK, Cobanoglu A, Johnston W. FK506-induced fulminant leukoencephalopathy after single-lung transplantation. Ann Thorac Surg 1997;64:1461-1464.